Omaveloxolone approved for patients aged 16 years and older with Friedreich ataxia (FRDA): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

• Arthur Lenahan,
• Sho Yano,
• Brett Graham,
• Kuntal Sen

Affiliations

Arthur Lenahan

Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA

Sho Yano

Section of Pediatric Neurology, Department of Pediatrics, University of Chicago, Chicago, IL

Brett Graham

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN

Kuntal Sen

Division of Neurogenetics and Neurodevelopmental Pediatrics, Center for Neuroscience and Behavioral Medicine, Children’s National Hospital, Washington, DC